Correlation Between Spyre Therapeutics and Mink Therapeutics

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Mink Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Mink Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Mink Therapeutics, you can compare the effects of market volatilities on Spyre Therapeutics and Mink Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Mink Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Mink Therapeutics.

Diversification Opportunities for Spyre Therapeutics and Mink Therapeutics

-0.1

Correlation Coefficient

Spyre Therapeutics  Mink Therapeutics

Good diversification

The 3 months correlation between Spyre and Mink is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Mink Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mink Therapeutics and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Mink Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mink Therapeutics has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Mink Therapeutics go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Mink Therapeutics

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Mink Therapeutics. In addition to that, Spyre Therapeutics is 1.65 times more volatile than Mink Therapeutics. It trades about -0.17 of its total potential returns per unit of risk. Mink Therapeutics is currently generating about 0.04 per unit of volatility. If you would invest  72.00  in Mink Therapeutics on August 31, 2024 and sell it today you would earn a total of  1.00  from holding Mink Therapeutics or generate 1.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  Mink Therapeutics

Spyre Therapeutics

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Spyre Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Mink Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's forward-looking signals remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Spyre Therapeutics and Mink Therapeutics

The main advantage of trading using opposite Spyre Therapeutics and Mink Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Mink Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mink Therapeutics will offset losses from the drop in Mink Therapeutics' long position.

The idea behind Spyre Therapeutics and Mink Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.